Whereas PD-L1 expression scores of CPS < 1%, 1% to 10%, and ≥10% were observed in 61.1%, 13.9%, and 25% of cases among stage I–III resected NSCLC patients. The gene discussed is CD274; the disease is non-small cell lung carcinoma.